These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7554448)

  • 1. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides.
    Kuwana M; Medsger TA; Wright TM
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 1):266-78. PubMed ID: 7554448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant topoisomerase I ELISA: screening for IgG, IgM and IgA anti-topo I autoantibodies in human sera.
    Verheijen R; de Jong BA; van Venrooij WJ
    Clin Exp Immunol; 1992 Sep; 89(3):456-60. PubMed ID: 1325307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis.
    Martínez-Cordero E; Trejo AP; León DE
    J Clin Lab Anal; 2009; 23(6):408-16. PubMed ID: 19927342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against topoisomerase I detected with the natural enzyme and overlapping recombinant peptides.
    Seelig HP; Schröter H; Ehrfeld H; Renz M
    J Immunol Methods; 1993 Oct; 165(2):241-52. PubMed ID: 8228274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunodominant epitope on DNA topoisomerase I is conformational in nature: heterogeneity in its recognition by systemic sclerosis sera.
    Kuwana M; Kaburaki J; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Jun; 42(6):1179-88. PubMed ID: 10366110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-Cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis.
    Rizou C; Ioannidis JP; Panou-Pomonis E; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM; Vlachoyiannopoulos PG
    Am J Respir Cell Mol Biol; 2000 Mar; 22(3):344-51. PubMed ID: 10696071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
    Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
    Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.
    Kuwana M; Kaburaki J; Arnett FC; Howard RF; Medsger TA; Wright TM
    Arthritis Rheum; 1999 Mar; 42(3):465-74. PubMed ID: 10088769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of anti-topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
    Henes J; Glaeser L; Kötter I; Vogel W; Kanz L; Klein R
    Rheumatology (Oxford); 2017 Mar; 56(3):451-456. PubMed ID: 27940597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Anti-Topoisomerase I Antibody Testing by Multiple-Bead, Enzyme-Linked Immunosorbent Assay and Immunodiffusion in a University Setting.
    Homer KL; Warren J; Karayev D; Khanna PP; Young A; Nagaraja V; Metzger AL; Khanna D
    J Clin Rheumatol; 2020 Apr; 26(3):115-118. PubMed ID: 30585996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Anti-Topoisomerase I Antibodies of the IgM Isotype With Disease Progression in Anti-Topoisomerase I-Positive Systemic Sclerosis.
    Boonstra M; Bakker JA; Grummels A; Ninaber MK; Ajmone Marsan N; Wortel CM; Huizinga TWJ; Jordan S; Hoffman-Vold AM; Distler O; Toes REM; Scherer HU; de Vries-Bouwstra JK
    Arthritis Rheumatol; 2020 Nov; 72(11):1897-1904. PubMed ID: 32840062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anti-topoisomerase I antibodies using a full length human topoisomerase I recombinant protein purified from a baculovirus expression system.
    Whyte J; Earnshaw WC; Champoux JJ; Parker LH; Stewart L; Hall ND; McHugh NJ
    Clin Exp Immunol; 1995 May; 100(2):214-8. PubMed ID: 7743657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular recognition patterns of anti-topoisomerase I-antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation.
    Glaeser L; Henes J; Kötter I; Vogel W; Kanz L; Klein R
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):28-35. PubMed ID: 29465357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis.
    Hu PQ; Fertig N; Medsger TA; Wright TM
    Arthritis Rheum; 2003 May; 48(5):1363-73. PubMed ID: 12746909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance.
    Kramer K; Pecher AC; Henes J; Klein R
    Clin Exp Rheumatol; 2024 Aug; 42(8):1571-1580. PubMed ID: 38530662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-DNA topoisomerase II alpha autoantibodies in Japanese patients with systemic sclerosis.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arch Dermatol Res; 2005 Oct; 297(4):180-3. PubMed ID: 16180014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA.
    Bankamp L; Preuß B; Pecher AC; Beucke N; Henes J; Klein R
    Front Immunol; 2021; 12():786039. PubMed ID: 34956217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins.
    Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC
    J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.